Literature DB >> 7936240

Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease: evidence of shared genetic susceptibility.

D Majoor-Krakauer1, R Ottman, W G Johnson, L P Rowland.   

Abstract

Clinicians have long suspected an association of classic amyotrophic lateral sclerosis (ALS) with Parkinson's disease (PD), dementia, or both. If proven, this would raise the possibility of a shared genetic susceptibility to the three disorders. To investigate this hypothesis, we compared 151 newly diagnosed ALS patients (seven familial) with 140 controls in terms of cumulative incidence of ALS, PD, and dementia in parents, siblings, and grandparents. We used Cox proportional hazards analysis to compute rate ratios (RRs) for ALS, dementia, and PD in relatives of ALS patients versus relatives of controls. The risk for dementia was significantly higher in relatives of ALS patients than in those of controls (RR = 1.9; 95% CI 1.1-3.1) and was similar for relatives of patients with sporadic and familial ALS. The risk of PD was higher in relatives of patients with familial ALS (RR = 5.6; 95% CI 0.6-50.3) than in relatives of patients with sporadic ALS (RR = 1.8; 95% CI 0.5-6.0), but these differences were not statistically significant, probably due to insufficient statistical power with the available sample size. These findings indicate that ALS and dementia, and perhaps also PD, co-occur within families more often than expected by chance, suggesting that there may be a shared genetic susceptibility to these disorders.

Entities:  

Mesh:

Year:  1994        PMID: 7936240     DOI: 10.1212/wnl.44.10.1872

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  24 in total

Review 1.  How to improve the diagnostic process.

Authors:  A Eisen
Journal:  J Neurol       Date:  1999-11       Impact factor: 4.849

2.  Polymorphism of rs3737597 in DISC1 Gene on Chromosome 1q42.2 in sALS Patients: a Chinese Han Population Case-Control Study.

Authors:  Libin Deng; Liwei Huo; Jie Zhang; Xiaoli Tang; Zhujun Cheng; Gang Li; Xin Fang; Jinsong Xu; Xiong Zhang; Renshi Xu
Journal:  Mol Neurobiol       Date:  2016-04-07       Impact factor: 5.590

Review 3.  Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials.

Authors:  Paul H Gordon
Journal:  Aging Dis       Date:  2013-10-01       Impact factor: 6.745

Review 4.  Amyotrophic lateral sclerosis: pathophysiology, diagnosis and management.

Authors:  Paul H Gordon
Journal:  CNS Drugs       Date:  2011-01       Impact factor: 5.749

5.  Frequency of the apolipoprotein E epsilon 4 allele in a case-control study of early onset Parkinson's disease.

Authors:  A S Whitehead; S Bertrandy; F Finnan; A Butler; G D Smith; Y Ben-Shlomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

Review 6.  Amyotrophic lateral sclerosis: human challenge for neuroscience.

Authors:  L P Rowland
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Potential therapeutic drugs and methods for the treatment of amyotrophic lateral sclerosis.

Authors:  G Yacila; Y Sari
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

Review 8.  Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein.

Authors:  Vladimir N Uversky; David Eliezer
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

9.  Familial aggregation of amyotrophic lateral sclerosis.

Authors:  Fang Fang; Freya Kamel; Paul Lichtenstein; Rino Bellocco; Pär Sparén; Dale P Sandler; Weimin Ye
Journal:  Ann Neurol       Date:  2009-07       Impact factor: 10.422

10.  Sequence of the superoxide dismutase 1 (SOD 1) gene in familial Parkinson's disease.

Authors:  O Bandmann; M B Davis; C D Marsden; A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-07       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.